2F-Viminol Explained

2F-Viminol is a pyrrole derived opioid analgesic drug, which was originally developed by a team at the drug company Zambon in the 1960s. It is around twice as potent as the parent compound viminol, though unlike viminol, 2F-viminol has never passed clinical trials or been approved for medical use. 2F-Viminol has been sold as a designer drug, first being identified in Sweden in 2019.^[1] It is one of a number of structurally atypical opioid agonists to have appeared on the designer drug grey-market since broad controls over fentanyl analogues were introduced in China in 2015.^[2] It was made illegal in Sweden in August 2019 and in Latvia in November 2019.^[3]

See also

• AP-237
• Brorphine
• Isotonitazene
• Z4349

Notes and References

1. Web site: Ordinance banning certain products that are harmful to health . Swedish Code of Statutes . 4 July 2019 . This Ordinance enters into force on 6 August 2019 .
2. Bao Y, Meng S, Shi J, Lu L . Control of fentanyl-related substances in China . The Lancet. Psychiatry . 6 . 7 . e15 . July 2019 . 31230685 . 10.1016/S2215-0366(19)30218-4 . free .
3. Web site: SPKC nosaka aizliegumu vielām 2F-viminol, furanyl UF – 17 un to saturošiem izstrādājumiem . SPKC bans 2F-viminol, furanyl UF-17 and products containing them . Latvian . Slimību profilakses un kontroles centrs (Center for Disease Prevention and Control) . 6 November 2019 .